Changeflow GovPing Healthcare & Life Sciences Daiichi Sankyo SF-1 Antagonist 3-Phenylpropylam...
Routine Notice Added Final

Daiichi Sankyo SF-1 Antagonist 3-Phenylpropylamine Derivative Patent

Favicon for changeflow.com USPTO Patent Grants - Organic Chemistry (C07D)
Published
Detected
Email

Summary

The USPTO granted patent US12606533B2 to Daiichi Sankyo Company, Limited for a 3-phenylpropylamine derivative compound exhibiting SF-1 antagonist activity. The patent contains 29 claims and relates to the compound as well as polyfunctional molecules containing the compound moiety, including SF-1 degraders.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The USPTO issued patent US12606533B2 to Daiichi Sankyo Company, Limited, covering a 3-phenylpropylamine derivative compound with SF-1 antagonist activity and related polyfunctional molecules. The patent contains 29 claims under CPC classification C07D 309/04.

For Daiichi Sankyo, the patent grant provides enforceable intellectual property rights in the United States, potentially blocking competitors from developing similar SF-1 antagonist compounds for the patent term. Competitors in the nuclear receptor or endocrine therapy space should review their compound pipelines for potential overlap with the claimed subject matter.

Archived snapshot

Apr 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

3-phenylpropylamine derivative

Grant US12606533B2 Kind: B2 Apr 21, 2026

Assignee

Daiichi Sankyo Company, Limited

Inventors

Hideaki Kageji, Tomoharu Tsukada, Takashi Tsuji, Masaya Fujii, Yuuichi Sugimoto, Yuto Tsuchiya, Keigo Murakami, Hidekazu Inoue, Masayuki Ebisawa, Naoki Kuki, Noriyuki Hayashi, Tetsuyoshi Matsufuji, Takashi Asahi, Saki Banjo, Shinji Tsutsumi, Mariko Shimonaga, Takuya Igarashi

Abstract

The present invention aims to provide a novel compound having SF-1 antagonist activity and a polyfunctional molecule containing a moiety corresponding to the compound, particularly an SF-1 degrader. The present invention relates to a 3-phenylpropylamine derivative compound represented by the formula (1) and the like, and a polyfunctional molecule containing a moiety corresponding to the compound represented by the formula (1) and the like.

CPC Classifications

C07D 309/04

Filing Date

2025-04-11

Application No.

19177410

Claims

29

View original document →

Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 21st, 2026
Instrument
Notice
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent grant IP registration
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!